Keros Therapeutics, Inc. (KROS)
NASDAQ: KROS · Real-Time Price · USD
11.20
-0.12 (-1.06%)
Sep 8, 2026, 9:30 AM EDT - Market open
Keros Therapeutics Stock Forecast
Stock Price Forecast
According to 7 analysts polled by S&P Global, Keros Therapeutics stock has a consensus rating of "Buy" and an average price target of $19.83. The average 1-year stock price forecast is 77.05% higher than the current stock price, while the lowest is $16 (+42.86%) and the highest is $25 (+123.21%).
Price Target: $19.83 (+77.05%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Keros Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | May '26 | Jun '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 5 | 5 | 4 | 4 | 4 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 4 | 4 | 4 | 4 | 4 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 9 | 9 | 8 | 8 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Buy Maintains $18 | Buy | Maintains | $18 | +60.71% | Sep 2, 2026 |
| Bank of America Securities | Bank of America Securities | Hold Reiterates $20 → $17 | Hold | Reiterates | $20 → $17 | +51.79% | Aug 11, 2026 |
| Wedbush | Wedbush | Hold Maintains $16 | Hold | Maintains | $16 | +42.86% | Aug 4, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $20 | Buy | Reiterates | $20 | +78.57% | Aug 4, 2026 |
| William Blair | William Blair | Hold Maintains n/a | Hold | Maintains | n/a | n/a | Aug 4, 2026 |
Financial Forecast
Revenue This Year
15.57M
from 244.06M
Decreased by -93.62%
Revenue Next Year
13.73M
from 15.57M
Decreased by -11.83%
EPS This Year
-5.22
from 2.30
EPS Next Year
-6.62
from -5.22
EPS and Forward PE are based on non-GAAP adjusted numbers.